Key Challenges in Oncology and Bioinformatics
This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Oncology/Bioinformatics events,...
1 month agoKey Challenges in Oncology and Bioinformatics
This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Oncology/Bioinformatics events,...
1 month ago
The Future of Clinical Trials and Pharmacovigilance
This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Clinical Trials/Pharmacovigilance...
1 month agoThe Future of Clinical Trials and Pharmacovigilance
This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Clinical Trials/Pharmacovigilance...
1 month ago
Weekly News Round-up – 7/8/20
In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested...
1 month agoWeekly News Round-up – 7/8/20
In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested...
1 month ago
Personalised Medicine Strategies – Providing More Clinical Benefit
Current personalised medicine strategies provide limited clinical benefit – how do we do better? Luckily Dr Allan Jordan, the Director of Oncology Drug Discovery at leading CRO Sygnature Discovery, was on hand to explain how. Here's another chance to watch...
2 months agoPersonalised Medicine Strategies – Providing More Clinical Benefit
Current personalised medicine strategies provide limited clinical benefit – how do we do better? Luckily Dr Allan Jordan, the Director of Oncology Drug Discovery at leading CRO Sygnature Discovery, was on hand to explain how. Here's another chance to watch...
2 months ago
Key Challenges in Medicinal Chemistry and Biology
This year Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Medicinal Chemistry...
2 months agoKey Challenges in Medicinal Chemistry and Biology
This year Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Medicinal Chemistry...
2 months ago
Weekly News Round-up – 17/7/20
In the news this week, despite significant alarms recently that GSK’s belantamab mafodotin could endanger patients’ eyes, the multiple myeloma drug has been approved by expert advisers. In other news, Novartis promises to make no profit from 15 of its COVID...
2 months agoWeekly News Round-up – 17/7/20
In the news this week, despite significant alarms recently that GSK’s belantamab mafodotin could endanger patients’ eyes, the multiple myeloma drug has been approved by expert advisers. In other news, Novartis promises to make no profit from 15 of its COVID...
2 months agoInterested?
Reserve your space
